Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-07-14FDA Approved: ELAHERE — Supplemental Application (ImmunoGen, Inc.)
The FDA approved a supplemental application for ELAHERE (mirvetuximab soravtansine) from ImmunoGen, Inc., updating the product labeling.